Literature DB >> 1793482

Mutations in the p53 tumor suppressor gene in human cutaneous squamous cell carcinomas.

W E Pierceall1, T Mukhopadhyay, L H Goldberg, H N Ananthaswamy.   

Abstract

In this study, we analyzed 10 human squamous cell carcinomas (SCCs) for alterations in the p53 tumor suppressor gene in exons 4 through 9 by single-strand conformation polymorphism (SSCP) analysis. We found that 2 of 10 SCCs displayed unusual SSCP alleles at exon 7 of the p53 gene. Subsequent cloning and sequencing of PCR-amplified exon 7 DNA from these two tumors revealed that one had a G----A transition at the first position of codon 244, predicting a glycine-to-serine amino acid change, while the other tumor exhibited a G----T base change at the second nucleotide of codon 248, predicting an arginine-to-leucine substitution. Because the mutations in the p53 tumor suppressor gene in both tumors were located opposite potential pyrimidine dimer sites (C-C), it is consistent with these mutations having been induced by the ultraviolet radiation present in sunlight. These studies demonstrate that inactivation of the p53 tumor suppressor gene, as well as activation of ras oncogenes, may be involved in the pathogenesis of some human skin cancers.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1793482     DOI: 10.1002/mc.2940040606

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  20 in total

1.  Relationship of p53 mutations to epidermal cell proliferation and apoptosis in human UV-induced skin carcinogenesis.

Authors:  J G Einspahr; D S Alberts; J A Warneke; P Bozzo; J Basye; T M Grogan; M A Nelson; G T Bowden
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

Review 2.  p53 and the pathogenesis of skin cancer.

Authors:  Cara L Benjamin; Honnavara N Ananthaswamy
Journal:  Toxicol Appl Pharmacol       Date:  2006-12-15       Impact factor: 4.219

3.  Activation of S6 signaling is associated with cell survival and multinucleation in hyperplastic skin after epidermal loss of AURORA-A Kinase.

Authors:  Weston Kenneth Ryan; Josiah Fernandez; Mikayla Katherine Peterson; David William Sheneman; Brendan Keefe Podell; Subhajyoti De; Enrique Carlo Torchia
Journal:  Cell Death Differ       Date:  2018-07-26       Impact factor: 15.828

Review 4.  UV signature mutations.

Authors:  Douglas E Brash
Journal:  Photochem Photobiol       Date:  2014-11-28       Impact factor: 3.421

5.  Defining the origins of Ras/p53-mediated squamous cell carcinoma.

Authors:  Andrew C White; Kathy Tran; Joan Khuu; Christine Dang; Yongyan Cui; Scott W Binder; William E Lowry
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-18       Impact factor: 11.205

6.  Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers.

Authors:  A Ziegler; D J Leffell; S Kunala; H W Sharma; M Gailani; J A Simon; A J Halperin; H P Baden; P E Shapiro; A E Bale
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

7.  p53 alterations in human squamous cell carcinomas and carcinoma cell lines.

Authors:  J Caamano; S Y Zhang; E A Rosvold; B Bauer; A J Klein-Szanto
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

8.  UV and skin cancer: specific p53 gene mutation in normal skin as a biologically relevant exposure measurement.

Authors:  H Nakazawa; D English; P L Randell; K Nakazawa; N Martel; B K Armstrong; H Yamasaki
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

9.  Benzo[a]pyrene-induced murine skin tumors exhibit frequent and characteristic G to T mutations in the p53 gene.

Authors:  B Ruggeri; M DiRado; S Y Zhang; B Bauer; T Goodrow; A J Klein-Szanto
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

10.  Immunohistochemical detection of p53 protein in cutaneous lesions from transplant recipients harbouring human papillomavirus DNA.

Authors:  I Pélisson; Y Chardonnet; S Euvrard; D Schmitt
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.